Literature DB >> 1768611

Effects of simultaneous diabetes and hypertension in an insulin dependent diabetic model.

M S Mozaffari1, S Jirakulsomchok, J M Wyss.   

Abstract

Several lines of evidence suggest that hypertension is a contributing factor to diabetic nephropathy, a major cause of mortality in diabetes mellitus patients. The present study tested the hypotheses (1) that insulin dependent diabetes (IDD) causes hypertension, and (2) that simultaneous hypertension and IDD causes greater renal damage than would be expected from the independent contributions of each disease. IDD was induced by injection of streptozotocin (STZ, 65 mg/kg i.p.) into male Wistar rats, causing severe hyperglycaemia within 4 days. Seven days after the STZ treatment, hypertension was initiated by subcutaneous implantation of deoxycorticosterone acetate and administration of 1% saline in the drinking water (DOCA-NaCl). IDD rats not receiving DOCA-NaCl displayed a small elevation of blood pressure one week after STZ treatment, but thereafter displayed significant hypotension. The IDD rats receiving DOCA-NaCl displayed elevated systolic arterial pressure throughout the study, but by the end of the experiment, their mean systolic arterial pressure was significantly lower than that of the rats treated with DOCA-NaCl alone. Only the IDD/DOCA-NaCl rats displayed significant signs of renal dysfunction, i.e. greatly increased proteinuria and morphological renal damage, including marked distension of distal tubules and occasional casts. No other group displayed these abnormalities.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1768611      PMCID: PMC2002446     

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  17 in total

1.  Effect of insulin on short-circuit current across isolated frog skin in the presence of calcium and magnesium.

Authors:  F C HERRERA; G WHITTEMBURY; A PLANCHART
Journal:  Biochim Biophys Acta       Date:  1963-01-15

2.  Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension.

Authors:  R Zatz; B R Dunn; T W Meyer; S Anderson; H G Rennke; B M Brenner
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

3.  The effect of sulfonylurea therapy on defective calcium movement associated with diabetic cardiomyopathy.

Authors:  M S Mozaffari; S Allo; S W Schaffer
Journal:  Can J Physiol Pharmacol       Date:  1989-11       Impact factor: 2.273

4.  Diabetogenic action of streptozotocin: relationship of dose to metabolic response.

Authors:  A Junod; A E Lambert; W Stauffacher; A E Renold
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

5.  The effects of Goldblatt hypertension on development of the glomerular lesions of diabetes mellitus in the rat.

Authors:  S M Mauer; M W Steffes; S Azar; S K Sandberg; D M Brown
Journal:  Diabetes       Date:  1978-07       Impact factor: 9.461

6.  NaCl does not affect hypothalamic noradrenergic input in deoxycorticosterone acetate/NaCl and Dahl salt-sensitive rats.

Authors:  Y F Chen; Q C Meng; J M Wyss; H K Jin; C F Rogers; S Oparil
Journal:  Hypertension       Date:  1990-07       Impact factor: 10.190

7.  Glomerular prostaglandin production in diabetic rats with renovascular hypertension.

Authors:  R T Kopecky; E T Schroeder
Journal:  Kidney Int       Date:  1988-06       Impact factor: 10.612

Review 8.  Glomerular hemodynamic and structural alterations in experimental diabetes mellitus.

Authors:  M P O'Donnell; B L Kasiske; W F Keane
Journal:  FASEB J       Date:  1988-05       Impact factor: 5.191

9.  Influence of short-term experimental diabetes on blood pressure and heart rate in response to norepinephrine and angiotensin II in the conscious rat.

Authors:  C V Jackson; G O Carrier
Journal:  J Cardiovasc Pharmacol       Date:  1983 Mar-Apr       Impact factor: 3.105

10.  Long-term improvement of metabolic control with the insulin pump does not reverse diabetic microangiopathy.

Authors:  W V Tamborlane; J E Puklin; M Bergman; C Verdonk; M C Rudolf; P Felig; M Genel; R Sherwin
Journal:  Diabetes Care       Date:  1982 May-Jun       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.